Heyndrickx G R, Vilaine J P, Moerman E J, Leusen I
Circ Res. 1984 Jun;54(6):683-93. doi: 10.1161/01.res.54.6.683.
We examined, in conscious dogs, the potential role of prejunctional alpha 2-adrenergic receptors for the regulation of heart rate and contractility response to exercise through modulation of the neurotransmitter release. Changes in heart rate and left ventricular pressure with time during comparable exercise levels, together with changes in norepinephrine concentration in the coronary sinus, were compared before and after the intravenous administration of: prazosin (0.5 mg/kg), a preferential postjunctional alpha 1-adrenergic receptor blocking agent; phentolamine (1 mg/kg), a nonselective alpha-adrenergic blocking agent; and yohimbine (0.3 mg/kg), a preferential prejunctional alpha 2-adrenergic receptor blocking agent. During exercise after phentolamine or yohimbine, changes in heart rate and left ventricular dP/dt were markedly potentiated compared to the control exercise, as well as to exercise after prazosin, whereas the norepinephrine concentration in the coronary sinus was substantially elevated. After intracoronary administration of phentolamine (0.1 mg/kg) or yohimbine (0.03 mg/kg), heart rate and contractility response to exercise were also potentiated, compared to the control exercise. These observations indicate that, in the intact conscious animal, prejunctional alpha 2-adrenoreceptors are stimulated during exercise, thereby modulating the norepinephrine release through a negative feedback inhibitory mechanism. Blocking these receptors by phentolamine or yohimbine results in an uncontrolled norepinephrine release during exercise associated with an augmented beta-adrenergic receptor-mediated end organ response, i.e., a potentiation in heart rate and contractility response.
我们在清醒犬中研究了接头前α₂ - 肾上腺素能受体通过调节神经递质释放对心率及运动时收缩性反应的潜在调节作用。在可比运动水平下,比较静脉注射以下药物前后心率和左心室压力随时间的变化,以及冠状窦中去甲肾上腺素浓度的变化:哌唑嗪(0.5mg/kg),一种选择性接头后α₁ - 肾上腺素能受体阻断剂;酚妥拉明(1mg/kg),一种非选择性α - 肾上腺素能阻断剂;育亨宾(0.3mg/kg),一种选择性接头前α₂ - 肾上腺素能受体阻断剂。在酚妥拉明或育亨宾注射后的运动过程中,与对照运动以及哌唑嗪注射后的运动相比,心率和左心室dP/dt的变化显著增强,而冠状窦中的去甲肾上腺素浓度大幅升高。冠状动脉内注射酚妥拉明(0.1mg/kg)或育亨宾(0.03mg/kg)后,与对照运动相比,运动时的心率和收缩性反应也增强。这些观察结果表明,在完整的清醒动物中,运动期间接头前α₂ - 肾上腺素能受体被激活,从而通过负反馈抑制机制调节去甲肾上腺素的释放。用酚妥拉明或育亨宾阻断这些受体导致运动期间去甲肾上腺素释放不受控制,伴有β - 肾上腺素能受体介导的终末器官反应增强,即心率和收缩性反应增强。